» Authors » Magdalena Rosinska

Magdalena Rosinska

Explore the profile of Magdalena Rosinska including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 142
Citations 1939
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gottlob A, Schmitt T, Frydensberg M, Rosinska M, Leclercq V, Habimana K
Eur J Public Health . 2025 Jan; 35(1):35-41. PMID: 39749896
The COVID-19 pandemic challenged healthcare delivery, especially cancer care. Telemedicine emerged as an important tool to reduce disease transmission risks, maintain continuity of care, and improve accessibility. This study explores...
2.
Borowiec A, Ozdowska P, Rosinska M, Zebrowska A, Jagiello-Gruszfeld A, Jasek S, et al.
Cardiooncology . 2024 Sep; 10(1):64. PMID: 39342402
Background: The presence and burden of coronary artery calcium (CAC) is a strong predictor of cardiovascular events. Current guidelines of the European Society of Cardiology (ESC) for cardio-oncology do not...
3.
Teterycz P, Szostakowski B, Rosinska M, Krzyzanowska K, Rutkowski P
Eur J Surg Oncol . 2024 Aug; 50(10):108604. PMID: 39151309
1 BACKGROUND: COVID-19 pandemic had a major impact on the healthcare system globally. This work aims to evaluate COVID-19 impact on local treatment in bone sarcoma treated in a single,...
4.
Rosinska M, Czarkowski M, Sadkowska-Todys M
Przegl Epidemiol . 2024 May; 77(4):411-428. PMID: 38783652
OBJECTIVE OF THE WORK. As 2021 was the second year of COVID-19 pandemic we expect the continuous impact of the pandemic on other infectious diseases. We aimed at reviewing the...
5.
Rosinska M, Dubianski R, Konieczna A, Poleszczuk J, Pawlik H, Nowecki Z, et al.
Cancers (Basel) . 2024 Mar; 16(6). PMID: 38539422
Triple-negative breast cancer (TNBC) poses a serious therapeutic challenge due to the occurrence of frequently aggressive, heterogenic, and metastatic tumours. The absence of therapeutic targets for traditional therapies is a...
6.
Thomadakis C, Gountas I, Duffell E, Gountas K, Bluemel B, Seyler T, et al.
Lancet Reg Health Eur . 2024 Jan; 36:100792. PMID: 38188273
Background: Epidemiological data are crucial to monitoring progress towards the 2030 Hepatitis C Virus (HCV) elimination targets. Our aim was to estimate the prevalence of chronic HCV infection (cHCV) in...
7.
Borowiec A, Rosinska M, Kowalik I, Rybski S, Chwyczko T, Jankowski J, et al.
Rev Port Cardiol . 2023 Dec; 43(3):97-103. PMID: 38122897
Introduction And Objectives: Granulomatosis with polyangiitis (GPA) is an antineutrophil cytoplasmic autoantibody (ANCA)-associated systemic vasculitis and is characterized by inflammation of blood vessels. The aim of the present study was...
8.
Kotronia E, Rosinska M, Stepien M, Czerwinski M, Sadkowska-Todys M
Front Public Health . 2023 Dec; 11:1235585. PMID: 38111477
Introduction: Despite the availability, safety and effectiveness of COVID-19 vaccines, Poland remains one of the six countries of the European Union with the lowest cumulative uptake of the vaccine's primary...
9.
Uuskula A, Rannap J, Weijler L, Abagiu A, Arendt V, Barrio G, et al.
Addiction . 2023 Nov; 118(11):2177-2192. PMID: 37991429
Aims: We measured the association between a history of incarceration and HIV positivity among people who inject drugs (PWID) across Europe. Design, Setting And Participants: This was a cross-sectional, multi-site,...
10.
Zakrzewska K, Stepien M, Rosinska M
Przegl Epidemiol . 2023 Oct; 77(2):220-232. PMID: 37860855
Background: In 2021, the COVID-19 pandemic continued, however, due to the implementation of vaccination, fewer disruptions were observed in healthcare. In the detection of HCV - inextricably linked to access...